Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cero Therapeutics Holdings, Inc. (CERO)
:CERO
Holding CERO?
Track your performance easily
CERO Stock Chart & Stats
Day’s Range― - ―
52-Week Range$2.21 - $1,280.00
Previous Close$3.66
Volume998.67K
Average Volume (3M)764.92K
Market Cap
$6.08M
Enterprise ValueN/A
Total Cash (Recent Filing)$1.10M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-2.28
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-43.79
Shares Outstanding2,600,000
10 Day Avg. Volume1,392,344
30 Day Avg. Volume764,923
Standard Deviation0.32
R-Squared0.00660
Alpha-0.07
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
CERo Therapeutics Holdings News
PremiumCompany Announcements
CERo Therapeutics Appoints New CEO to Lead Innovations
Ownership Overview
37.82% Insiders
0.03% Mutual Funds
1.59% Other Institutional Investors
60.57% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
CERO FAQ
What was Cero Therapeutics Holdings, Inc.’s price range in the past 12 months?
Cero Therapeutics Holdings, Inc. lowest stock price was $2.21 and its highest was $1280.00 in the past 12 months.
What is Cero Therapeutics Holdings, Inc.’s market cap?
Cero Therapeutics Holdings, Inc.’s market cap is $6.08M.
When is Cero Therapeutics Holdings, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Cero Therapeutics Holdings, Inc.’s earnings last quarter?
Currently, no data Available
Is Cero Therapeutics Holdings, Inc. overvalued?
According to Wall Street analysts Cero Therapeutics Holdings, Inc.’s price is currently Overvalued.
Does Cero Therapeutics Holdings, Inc. pay dividends?
Cero Therapeutics Holdings, Inc. does not currently pay dividends.
What is Cero Therapeutics Holdings, Inc.’s EPS estimate?
Cero Therapeutics Holdings, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cero Therapeutics Holdings, Inc. have?
Cero Therapeutics Holdings, Inc. has 2,600,000 shares outstanding.
What happened to Cero Therapeutics Holdings, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Cero Therapeutics Holdings, Inc.?
Among the largest hedge funds holding Cero Therapeutics Holdings, Inc.’s share is Saba Capital Management. It holds Cero Therapeutics Holdings, Inc.’s shares valued at 0.
---
Company Description
Cero Therapeutics Holdings, Inc.
Phoenix Biotech Acquisition Corp is a blank check company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
---
Technical Analysis
---